Open
1,336.00
Prev. Close
1,328.70
Total Traded Value
87.16 Cr
Market Cap (in crs)
25,176.65
Face Value
10
Turnover (in lacs)
8,716.04
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
*All values are in ₹ Cr.
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
2116.24 Cr | 1962.63 Cr | 2001.98 Cr | 1815.14 Cr | 1771.36 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
7963.26 Cr | 6715.24 Cr | 6031.72 Cr | 5918.86 Cr |
Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
---|---|---|---|---|
197.24 Cr | 156.09 Cr | 201.55 Cr | 152.59 Cr | 121.02 Cr |
Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
---|---|---|---|
707.47 Cr | 527.58 Cr | 561.84 Cr | 702.56 Cr |
Emcure Pharmaceuticals Ltd reported a 9.3% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Mar (Q4FY25). On a year-on-year (YoY) basis, it witnessed a - of -.
Its expenses for the quarter were down by 6.9% QoQ and - - YoY.
The net profit decreased 22.5% QoQ and - - YoY.
The earnings per share (EPS) of Emcure Pharmaceuticals Ltd stood at 6.4 during Q4FY25.
Data Source: BSE, Company announcements
The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.
Period | Combined Delivery Volume | NSE+BSE Traded Volume |
---|---|---|
Day Rs | 53172 Rs | 98385 Rs |
Week Rs | 154203 Rs | 236777 Rs |
Month Rs | 133793 Rs | 279427 Rs |
Index Name | Market Price | Market Cap | 52W Low | 52W High | Prev. Close | 1W Return | 1M Return | 6M Return | 1Y Return | 3Y Return | Dividend Yield | PE Ratio | Industry PE | PB Ratio |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
- | 25,172.50 | 6069.7 | 10691 | 10,069.00 | -2.36% | 24.20% | 50.17% | 51.17% | 254.14% | 0.00% | 143.98 | 41.89 | 32.72 | |
- | 26,156.81 | 599.55 | 960.6 | 649.15 | -2.72% | -0.13% | -25.00% | -8.91% | 19.76% | 0.19% | 58.94 | 47.67 | 5.64 | |
- | 24,348.00 | 987.1 | 1910 | 1,787.70 | 3.78% | 21.55% | 28.14% | 69.79% | 186.34% | 0.41% | 314.45 | 41.89 | 9.67 | |
- | 38,069.26 | 696.05 | 1360 | 995.10 | 0.73% | -6.45% | -19.00% | 34.89% | 125.21% | 0.00% | 139.80 | 41.89 | 16.31 | |
- | 25,954.90 | 145.25 | 307.9 | 195.26 | -5.44% | -5.61% | -26.95% | 24.03% | 0.00% | 0.07% | 37.51 | 41.89 | 3.48 | |
- | 24,834.91 | 1209.95 | 2248 | 2,170.20 | 6.99% | 37.49% | 0.00% | 0.00% | 0.00% | 0.00% | 186.87 | 41.89 | 4.18 |
As of 18 Jun, 2025, Emcure Pharmaceuticals share price is ₹1338.9. The stock opened at ₹1336 and had closed at ₹1328.7 the previous day. During today’s trading session, Emcure Pharmaceuticals share price moved between ₹1,314.00 and ₹1,357.80, with an average price for the day of ₹1.00. Over the last 52 weeks, the stock has recorded a low of ₹889.00 and a high of ₹1,580.00. In terms of performance, Emcure Pharmaceuticals share price has declined by 3.4% over the past six months and has declined by 2.24% over the last year.
Emcure Pharmaceuticals share price is ₹1337.9 in NSE and ₹1342 in BSE as on 18/6/2025.
Emcure Pharmaceuticals share price in the past 1-year return was 0. The Emcure Pharmaceuticals share hit a 1-year low of Rs. 889 and a 1-year high of Rs. 1580.
The market cap of Emcure Pharmaceuticals is Rs. 25176.65 Cr. as of 18/6/2025.
The PE ratios of Emcure Pharmaceuticals is 79.27 as of 18/6/2025.
The PB ratios of Emcure Pharmaceuticals is 8.31 as of 18/6/2025
The Mutual Fund Shareholding in Emcure Pharmaceuticals was 2.73% at the end of 18/6/2025.
You can easily buy Emcure Pharmaceuticals shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Emcure Pharmaceuticals stock prices are subject to continuous fluctuations due to various factors.